|
Volumn 22, Issue 4, 1998, Pages 293-304
|
Predictive factors of tumor response and prognostic factors of survival during lung cancer chemotherapy
a a a a |
Author keywords
Chemotherapy; CYFRA 21 1; Cytokeratins; Lung cancer; Neuron specific enolase; Survival; Tissue polypeptide specific antigen; Tumor markers; Tumor response
|
Indexed keywords
ANTIGEN CYFRA21.1;
ANTINEOPLASTIC AGENT;
ANTINEOPLASTIC ANTIBIOTIC;
CISPLATIN;
CYCLOPHOSPHAMIDE;
ENOLASE;
ETOPOSIDE;
KERATIN;
LACTATE DEHYDROGENASE;
TISSUE POLYPEPTIDE ANTIGEN;
TUMOR ANTIGEN;
TUMOR MARKER;
ANALYSIS OF VARIANCE;
ARTICLE;
BLOOD;
HUMAN;
LUNG NON SMALL CELL CANCER;
LUNG TUMOR;
MORTALITY;
PROGNOSIS;
REGRESSION ANALYSIS;
SMALL CELL CARCINOMA;
ANALYSIS OF VARIANCE;
ANTIBIOTICS, ANTINEOPLASTIC;
ANTIGENS, NEOPLASM;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CARCINOMA, NON-SMALL-CELL LUNG;
CARCINOMA, SMALL CELL;
CISPLATIN;
CYCLOPHOSPHAMIDE;
ETOPOSIDE;
HUMANS;
KERATINS;
L-LACTATE DEHYDROGENASE;
LUNG NEOPLASMS;
PHOSPHOPYRUVATE HYDRATASE;
PROGNOSIS;
REGRESSION ANALYSIS;
TISSUE POLYPEPTIDE ANTIGEN;
TUMOR MARKERS, BIOLOGICAL;
|
EID: 0031861632
PISSN: 0361090X
EISSN: None
Source Type: Journal
DOI: 10.1046/j.1525-1500.1998.CDOA43.x Document Type: Article |
Times cited : (48)
|
References (30)
|